Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  USANA Health Sciences, Inc.    USNA

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

USANA Health Sciences, Inc. : USANA Schedules First Quarter Earnings Release and Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:50pm CEST

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market Tuesday, April 24, 2012. USANA executives will hold a conference call to discuss this announcement with analysts and institutional investors the following morning at 11:00 a.m. Eastern Time.

The call will be broadcast over the Internet and can be accessed at http://www.usanahealthsciences.com.

The webcast is also being distributed over Thomson's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through Thomson's individual investor center at www.fulldisclosure.com or by visiting any of the investor sites in Thomson's Individual Investor Network. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

About USANA

USANA develops and manufactures high-quality nutritional, personal care, and weight-management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, the United Kingdom, Thailand, France and Belgium. Additionally, USANA's wholly owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.

USANA Health Sciences, Inc.
Patrique Richards, 801-954-7961
Investor Relations
[email protected]


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on USANA HEALTH SCIENCES, INC
10/14 USANA HEALTH SCIENCES : Launches Two New Products in Canada
10/09 USANA HEALTH SCIENCES : Schedules Third Quarter Earnings Release and Conference ..
10/09 USANA TRUE HEALTH FOUNDATION : Names New President
10/09 USANA HEALTH SCIENCES, INC. (NYSE : USNA) Files An 8-K Departure of Directors or..
10/06 USANA HEALTH SCIENCES INC : Change in Directors or Principal Officers, Financial..
10/05 USANA HEALTH SCIENCES : Announces Appointment of J. Scott Nixon to Board of Dire..
09/27 USANA : True Health Foundation Donates $50,000 To Victims Of Earthquake In Mexic..
09/12 USANA : Stands Committed to Ethical Business Practices
09/07 USANA HEALTH SCIENCES : An Application for the Trademark "OPTOMEGA" Has Been Fil..
09/07 USANA HEALTH SCIENCES : You Are What You Eat (And Drink)
More news
News from SeekingAlpha
10/18 Sorting Sham From Scam, The Debate Over Shopify And Herbalife
08/23 USANA announces new skincare line
08/21 Herbalife rally stokes MLM compatriots Nu Skin and USANA
08/18 USANA announces expansion in four European countries
08/15 WALL STREET BREAKFAST : More CEOs Resign From Trump Council
Financials ($)
Sales 2017 1 031 M
EBIT 2017 141 M
Net income 2017 93,0 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 16,27
P/E ratio 2018 14,15
Capi. / Sales 2017 1,44x
Capi. / Sales 2018 1,37x
Capitalization 1 488 M
Chart USANA HEALTH SCIENCES, INC
Duration : Period :
USANA Health Sciences, Inc Technical Analysis Chart | USNA | US90328M1071 | 4-Traders
Technical analysis trends USANA HEALTH SCIENCES, INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 70,5 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Kevin G. Guest Chief Executive Officer & Director
Jim Brown President & Chief Operating Officer
Myron W. Wentz Chairman
G. Douglas Hekking Chief Financial Officer
Robert Andrew Sinnott Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
USANA HEALTH SCIENCES, INC.-0.57%1 488
PROCTER & GAMBLE COMPANY10.34%236 565
UNILEVER (NL)33.58%180 852
UNILEVER38.15%180 529
UNILEVER NV (ADR)49.51%180 060
COLGATE-PALMOLIVE COMPANY13.75%65 570